US Patent 7626021 Fused ring heterocycle kinase modulators
Patent 7626021 was granted and assigned to SGX Pharmaceuticals on December, 2009 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7626021 Fused ring heterocycle kinase modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
